Hans H Hirsch
Overview
Explore the profile of Hans H Hirsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
280
Citations
6153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tilloy V, Diaz-Gonzalez D, Laplace L, Bisserier E, Chou S, Rawlinson W, et al.
Antiviral Res
. 2024 Sep;
231:106016.
PMID: 39349222
A comprehensive and accessible Herpesvirus drug resistance database was designed to serve as an international reference for diagnosis and clinical studies. This database available at https://www.unilim.fr/cnr-herpesvirus/outils/codexmv/includes both resistance-related mutations and...
12.
Wilhelm M, Geng A, Schaub S, Hirsch H
J Am Soc Nephrol
. 2024 Sep;
35(12):1784-1785.
PMID: 39302720
No abstract available.
13.
Hirsch H, Pape L, Tedesco Silva H, Kotton C
Transplantation
. 2024 Aug;
108(9):e277.
PMID: 39166904
No abstract available.
14.
Gutlin Y, Albertos Torres D, Gensch A, Schlotterbeck A, Stoger L, Heller S, et al.
Swiss Med Wkly
. 2024 Aug;
154:3408.
PMID: 39137369
Introduction: Quantifying antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and neutralising antibodies may help to understand protection at the individual and population levels. Determination of neutralising antibodies using...
15.
Fernbach S, Mair N, Abela I, Groen K, Kuratli R, Lork M, et al.
J Exp Med
. 2024 Jul;
221(9).
PMID: 39017930
Autoantibodies neutralizing type I interferons (IFN-Is) can underlie infection severity. Here, we trace the development of these autoantibodies at high-resolution using longitudinal samples from 1,876 well-treated individuals living with HIV...
16.
Ragozzino S, Kuehl R, Leuzinger K, Schlapfer P, Urwyler P, Durovic A, et al.
Antimicrob Resist Infect Control
. 2024 Jul;
13(1):73.
PMID: 38971822
The implementation of isolation precautions for patients with suspected Coronavirus Disease 2019 (COVID-19) and pending test results is resource intensive. Due to the limited availability of single-bed rooms at our...
17.
Naegele K, Bubendorf L, Hirsch H, Leuzinger K
J Med Virol
. 2024 May;
96(6):e29649.
PMID: 38812416
Persistent infection with high-risk human papillomavirus (HPV) is recognized as the main cause for the development of anogenital cancers. This study prospectively evaluated the diagnostic performance of the novel Allplex-HPV28...
18.
Begre L, Boyd A, Plissonnier M, Testoni B, Salazar-Vizcaya L, Suter-Riniker F, et al.
J Infect Dis
. 2024 Apr;
230(4):e954-e963.
PMID: 38626170
Background: We evaluated long-term trajectories of circulating hepatitis B virus (HBV) RNA and hepatitis B core-related antigen (HBcrAg) in persons with and without hepatitis B surface antigen (HBsAg) loss during...
19.
Kotton C, Kamar N, Wojciechowski D, Eder M, Hopfer H, Randhawa P, et al.
Transplantation
. 2024 Apr;
108(9):1834-1866.
PMID: 38605438
BK polyomavirus (BKPyV) remains a significant challenge after kidney transplantation. International experts reviewed current evidence and updated recommendations according to Grading of Recommendations, Assessment, Development, and Evaluations (GRADE). Risk factors...
20.
Drager S, Bruni F, Bernasconi M, Hammann-Hanni A, Jirasko V, Tanno A, et al.
Microorganisms
. 2024 Mar;
12(3).
PMID: 38543642
This study compared SARS-CoV-2 RNA loads at different anatomical sites, and the impact of self-swabbing and food intake. Adult symptomatic patients with SARS-CoV-2 or non-SARS-CoV-2 respiratory tract infection were included...